Highlights

25-10-30 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-09 Changchun High-Tech Unit Gets Approval for Combo Vaccine Trials; Shares Up 5% MT
25-08-29 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-04-20 Changchun BCHT Biotechnology Co. announces Annual dividend, payable on June 18, 2025 CI
25-04-20 Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-20 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-01-29 BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma MT
24-10-25 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-08-16 Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11% MT
24-08-08 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-04-24 Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine MT
24-04-19 Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-20 Changchun BCHT Biotechnology's 2023 Profit Soars 176% as Revenue Jumps 70% MT
24-02-26 BCHT Biotechnology's 2023 Profit Surges 176%; Shares Jump 4% MT
24-02-23 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
23-12-07 Changchun High-Tech Industry's Unit Gets Nod to Trial Rabies Vaccine MT
23-10-24 BCHT Biotechnology to Invest 805 Million Yuan in Flu Vaccine Factory MT
23-10-23 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
23-08-15 Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
No results for this search